Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07352579 · ClinicalTrials.gov registry record
From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care
A clinical trial of Cancer, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT07352579: Recruiting study of Cancer, sponsored by Thomas Jefferson University.
NCT07352579 is a study of Cancer that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 500 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07352579, a study of Cancer, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study aims to identify the factors that influence whether cancer patients accept or decline supportive care services after screening positive for health-related social needs (HRSNs) at the Sidney Kimmel Comprehensive Cancer Center. The study focuses on adult oncology patients who previously reported at least one HRSN-such as transportation, food, housing, or utility needs-but declined assistance when it was offered. The main questions it aims to answer are: * What factors shape cancer patients' intentions to use supportive care services for HRSNs? * Why do patients who screen positive for HRSNs choose not to accept help offered by the healthcare system? Participants will: * Complete a one-time electronic survey delivered via MyChart or email. * Optionally participate in a semi-structured Zoom interview (for a subset of 20-30 survey respondents) to explore decision-making in greater depth.
Primary Outcome
Measured via Surveys (self-reported) using a structured questionnaires with binary (Yes/No) responses and Likert Style questions (Quality of Life and FACT-ES).
Conditions Studied
Interventions
- OTHER Interview
- OTHER Survey
Study Locations (1)
Pennsylvania
- Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-12-11 |
| Est. Completion | 2027-01 |
What NCT07352579 shows while recruiting
NCT07352579 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Interview is the first listed.
NCT07352579 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07352579 about?
NCT07352579 is a clinical study titled "From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care". This observational study aims to identify the factors that influence whether cancer patients accept or decline supportive care services after screening positive for health-related social needs (HRSNs) at the Sidney Kimmel Comprehensive Cancer Center. The study focuses on adult oncology patients who...
What is the current status of trial NCT07352579?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-12-11. Estimated completion is 2027-01.
What conditions does trial NCT07352579 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT07352579?
The interventions under investigation include: Interview (OTHER), Survey (OTHER).
Who is sponsoring clinical trial NCT07352579?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07352579 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07352579's enrollment target sits among peer trials
500 122nd of 615 higher than 484 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI